Position in GILD
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$11,845,259
-$112,408 QoQ
Shares Held
93,757
+9.3% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#404
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ethic Inc. holds $332,739,634 across 14 Drug Manufacturers - General names. GILD ranks #9 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
90,920 | $109,052,184 | |
| 2 | MRK |
Merck & Co., Inc.
|
358,041 | $46,008,268 | |
| 3 | JNJ |
Johnson & Johnson
|
109,758 | $27,875,239 | |
| 4 | PFE |
Pfizer Inc
|
882,175 | $21,242,774 | |
| 5 | ABBV |
AbbVie Inc.
|
83,563 | $21,027,793 | |
| 6 | AMGN |
Amgen Inc
|
56,184 | $20,345,350 | |
| 7 | NVS |
Novartis AG
|
108,784 | $17,048,628 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
270,904 | $15,609,488 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,845,259 | 93,757 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $11,957,667 | 85,798 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $9,833,806 | 80,119 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $8,548,776 | 77,016 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $8,325,560 | 75,093 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $7,986,027 | 71,272 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $9,665,966 | 104,644 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $8,132,983 | 97,006 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $6,142,241 | 89,524 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $7,105,689 | 97,006 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $9,136,145 | 112,778 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $8,120,123 | 108,355 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $7,772,278 | 100,847 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $7,885,385 | 95,039 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $5,487,703 | 63,922 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,769,510 | 44,894 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,910,856 | 30,915 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $1,606,339 | 27,020 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,225,206 | 30,646 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,012,141 | 43,123 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $3,430,123 | 49,813 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $2,187,337 | 33,844 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,123,078 | 19,277 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $938,877 | 14,858 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $852,956 | 11,086 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $720,686 | 9,640 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||